Guidelines on prophylaxis to prevent infective endocarditis

British Dental Journal

Volumn 220, Issue 2, 2016, Pages 51-56

  Thornhill, M H ^a,b   Dayer, M ^b   Lockhart, P B ^b   Mcgurk, M ^c   Shanson, D ^d   Prendergast, B ^c   Chambers, J B ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b CAROLINAS MEDICAL CENTER   (United States)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADVERSE EFFECTS; ANTIBIOTIC PROPHYLAXIS; DENTAL PROCEDURE; ENDOCARDITIS; EVIDENCE BASED DENTISTRY; HUMAN; PRACTICE GUIDELINE; RISK FACTOR; STANDARDS; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DENTAL CARE; ENDOCARDITIS; EVIDENCE-BASED DENTISTRY; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; UNITED KINGDOM;

EID: 84955504266     PISSN: 00070610     EISSN: 17417503     Source Type: Journal    
DOI: 10.1038/sj.bdj.2016.49     Document Type: Review

References (24)

1. Cahill T J, Prendergast B D. Infective endocarditis. Lancet 2015; DOI: 10.1016/S0140-6736(15)00067-7
2. Lewis T, Grant R. Observations relating to subacute infective endocarditis. Heart 1923; 10: 21-77
3. National Institute for Health and Care Excellence (NICE). Prophylaxis against infective endocarditis. 2008. Available online at http://www.nice.org.uk/CG064 (accessed January 2016
4. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-2413
5. Wilson W, Taubert K A, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 1736-1754
6. Dayer M J, Jones S, Prendergast B, Baddour L M, Lockhart P B, Thornhill M H. Incidence of infective endocarditis in England, 2000-2013: a secular trend, interrupted time-series analysis. Lancet 2015; 385: 1219-1228
7. National Institute for Health and Care Excellence (NICE). Prophylaxis against infective endocarditis. 2015. Available online at http://www.nice.org.uk/guidance/indevelopment/gid-cgwave0748/docu-ments (accessed January 2016
8. Habib G, Lancellotti P, Antunes M J, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075-3128
9. UK Government. National Institute for Clinical Excellence (Establishment and Constitution) Order 1999 and 2005 ammendment. London: UK Government, 1999
10. Mohindra R K. A case of insufficient evidence equi-poise: the NICE guidance on antibiotic prophylaxis for the prevention of infective endocarditis. J Med Ethics 2010; 36: 567-570
11. Mohindra R K. NICE should not intervene where there is equipoise by virtue of insufficient evidence. Heart 2010; 96: 1333 (author reply
12. Thornhill M H, Lockhart P B, Prendergast B, Chambers J B, Shanson D. NICE and antibiotic prophylaxis to prevent endocarditis. Br Dent J 2015; 218: 619-621
13. Thornhill M H, Dayer M J, Prendergast B, Baddour L M, Jones S, Lockhart P B. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother 2015; 70: 2382-2388
14. Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. J Antimicrob Chemother 2007; 60: 1172-1173
15. Scully C, Robinson A N, Cameron J A. Clinical guid-ance: Guidance on guidance. Br Dent J 2015; 219: 194
16. Hurwitz B. Legal and political considerations of clini-cal practice guidelines. BMJ 1999; 318: 661-664
17. Woolf S H, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-530
18. UK) GDC. Standards for the dental team. 2015. Standards available online at https://www.gdc-uk.org/Dentalprofessionals/Standards/Documents/Standards for the Dental Team.pdf (accessed January 2016
19. Main B G, Adair S R. The changing face of informed consent. Br Dent J 2015; 219: 325-327
20. Southerland L. Montgomery in the Supreme Court: a new legal test for consent to medical treatment. 2015. Available online at http://www.scottishlegal.com/2015/03/12/montgomery-in-the-supreme-court-a-new-legal-test-for-consent-to-medical-treatment/(accessed January 2016
21. Montgomery v Lanarkshire Health Board (Scotland). UKSC 11; 2015
22. Edozien L C. UK law on consent finally embraces the prudent patient standard. BMJ 2015; 350: h2877
23. Bolam v Friern HMC. 2 All ER 118; 1957
24. Lockhart P B, Brennan M T, Thornhill M, et al. Poor oral hygiene as a risk factor for infective endocardi-tis-related bacteremia. J Am Dent Assoc 2009; 140: 1238-1244